Characteristics of studies that examined MDM2 SNP rs2279744
Reference | OR (95% CI) | P values | EAF | Ancestry | Cases (n) | Controls (n) | EC type | Dataset(s) |
Terry 200848 | 1.32 (1.11 to 1.56) | 0.002 | N/A | European | 591 | 1543 | N/A | NHS (Nurses’ Health Study), WHS (Women’s Health Study) |
Ashton 200949 | 1.37 (1.06 to 1.79) | N/A | 0.56 | Caucasian | 191 | 291 | All | Hospital based |
Nunobiki 200950 | 2.28 (2.02 to 2.54) | 0.030 | 0.49 | Japanese | 102 | 95 | All | Hospital based |
Ueda 200951 | 1.91 (1.5 to 3.47) | 0.035 | 0.51 | Japanese | 119 | 108 | All | Hospital based |
Wan 201143 | 1.54 (1.21 to 1.94) | 0.000 | N/A | N/A | N/A | N/A | N/A | Walsh 2007,36 Terry 2008, Ashton 2009, Nunobiki 2009, Ueda 2009 |
Li 201144 | 1.75 (1.16 to 2.63) | 0.007 | N/A | European, Asian | 1001 | 1889 | N/A | Walsh 2007, Terry 2008, Ashton 2009, Nunobiki 2009, Ueda 2009 |
Knappskog 201240 | 1.22 (1.03 to 1.44) | N/A | 0.36 | European | 392 | 956 | N/A | Hospital based |
Zajac 201227 | 1.33 (1.12 to 1.58) | 0.001 | N/A | European | 152 | 100 | N/A | Hospital based |
Yoneda 201352 | 1.64 (0.81 to 3.28) | 0.450 | 0.45 | Asian | 125 | 200 | All | Population based |
Peng 201341 | 1.6 (1.21 to 2.13) | 0.001 | N/A | European, Asian | 2069 | 4546 | N/A | Walsh 2007, Terry 2008, Ashton 2009, Nunobiki 2009, Knappskog 2012, Yoneda 2013 |
1.87 (1.29 to 2.73) | 0.010 | N/A | European | 1842 | 4251 | N/A | ||
Zhao 201453 | 1.41 (1.04 to 1.92) | 0.030 | N/A | European, Asian | 1278 | 2189 | N/A | Walsh 2007, Terry 2008, Ashton 2009, Ueda 2009, Zajac 2012, Yoneda 2013 |
1.34 (1.07 to 1.69) | N/A | N/A | European | 859 | 1707 | N/A | ||
Wang 201438 | 1.32 (1.06 to 1.64) | 0.010 | N/A | European, Asian | 1967 | 4460 | N/A | Walsh 2007, Terry 2008, Ashton 2009, Nunobiki 2009, Ueda 2009, Zajac 2012, Knappskog 2012, Yoneda 2013 |
1.14 (0.79 to 1.65) | 0.490 | N/A | European | 1769 | 4172 | N/A | ||
Xue 201642 | 1.46 (1.25 to 1.72) | N/A | N/A | European | 1690 | 4151 | N/A | Walsh 2007, Terry 2008, Ashton 2009, Nunobiki 2009, Ueda 2009, Zajac 2012, Knappskog 2012, Yoneda 2013 |
Zhang 201854 | 1.91 (1.5 to 3.47) | 0.035 | N/A | European, Asian | 762 | 1041 | N/A | Walsh 2007, Terry 2008, Ashton 2009, Nunobiki 2009, Ueda 2009, Zajac 2012 |
Zou 201855 | 1.23 (1.06 to 1.41) | 0.005 | N/A | European, Asian, mixed | 3535 | 6476 | All | Walsh 2007, Terry 2008, Ashton 2009, Ueda 2009, Knappskog 2012, Zajac 2012, Yoneda 2013, Okamoto 2015, Gansmo 201737 |
*Walsh et al 2007 and Gansmo et al 2017 did not meet eligibility criteria for us to include in our evaluation.
EAF, effect allele frequency; EC, endometrial cancer; SNP, single nucleotide polymorphism.